/Investor DB

Visionary Ventures — 2022 Investments

2 investments dated 2022 · listed companies and verified rows first · show all

Aurion Biotechaurionbiotech.cominApr 2022 · $120M

Aurion Biotech develops regenerative cell therapies for ophthalmology, focused on treating blindness and vision loss from corneal endothelial disease.

BiotechHealthtechMedical DevicesSeattle, US

DAVID ROSTOV(Executive Officer)inGREG KUNST(Executive Officer, Director)PATRICK LALLY(Director)JEANNETTE BANKES(Director)CHRISTINE MCCAULEY(Director)ARNAUD LACOSTE(Executive Officer)

Co-investorsDeerfield Management CompanyFlying L Partners

Vanavana.org𝕏Nov 2022 · $11.9M

Vana is an open data infrastructure platform that enables individuals to control and manage the data they generate, with the ability to choose how it is used by AI systems.

AI & Machine LearningCrypto & Web3Data & Infrastructure

Art Abal(Founder)Anna Kazlauskas(Founder)

Co-investorsAbstract VenturesAlphaLab CapitalBoxGroupCaladanEarl Grey CapitalFlori Ventures+15 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.